{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:17:01Z","timestamp":1791908221666,"version":"4.3.4"},"reference-count":106,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Emerging Microbes & Infections"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/emi.2016.10","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T03:23:16Z","timestamp":1454469796000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":184,"title":["Updates on the risk factors for latent tuberculosis reactivation and their managements"],"prefix":"10.1080","volume":"5","author":[{"given":"Jing-Wen","family":"Ai","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Ling","family":"Ruan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Hui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"e_1_3_2_1_1","unstructured":"World Health Organization. Global Tuberculosis Report 2015 . Geneva: WHO 2015. Available at http:\/\/www.who.int\/tb\/publications\/global_report\/en\/(accessed 23 November 2015)."},{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF02602749","article-title":"Interpretation of the tuberculin skin test","volume":"10","author":"Rose DN","year":"1995","unstructured":"RoseDN,SchecterCB,AdlerJJ .Interpretation of the tuberculin skin test.J Gen Intern Med1995; 10:635\u2013642.","journal-title":"J Gen Intern Med"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1753465813503028","article-title":"Treatment of latent tuberculosis infection","volume":"7","author":"Parekh MJ","year":"2013","unstructured":"ParekhMJ,SchlugerNW .Treatment of latent tuberculosis infection.Ther Adv Respir Dis2013; 7:351\u2013356.","journal-title":"Ther Adv Respir Dis"},{"key":"e_1_3_2_4_1","first-page":"1352","article-title":"Preventive chemotherapy. Where has it got us? Where to go next?","volume":"12","author":"Landry J","year":"2008","unstructured":"LandryJ,MenziesD .Preventive chemotherapy. Where has it got us? Where to go next?Int J Tuberc Lung Dis2008; 12:1352\u20131364.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies D","year":"2007","unstructured":"MenziesD,PaiM,ComstockG .Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.Ann Intern Med2007; 146:340\u2013354.","journal-title":"Ann Intern Med"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai M","year":"2004","unstructured":"PaiM,RileyLW,ColfordJMJr .Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.Lancet Infect Dis2004; 4:761\u2013776.","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi A","year":"2011","unstructured":"CattamanchiA,SmithR,SteingartKRet al.Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.J Acquir Immune Defic Syndr2011; 56:230\u2013238.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the United States","volume":"184","author":"Linas BP","year":"2011","unstructured":"Linas BP,Wong AY,Freedberg KA.Priorities for screening and treatment of latent tuberculosis infection in the United States.Am J Respir Crit Care Med2011; 184:590\u2013596.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","article-title":"Latent tuberculosis infection in the United States","volume":"364","author":"Horsburgh CR","year":"2011","unstructured":"HorsburghCR,RubinsEJ.Latent tuberculosis infection in the United States.N Engl J Med2011; 364:1441\u20131448.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_10_1","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society.Targeted tuberculin testing and treatment of latent tuberculosis infection.MMWR Recomm Rep2000; 49:1\u201351.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka MX","year":"2012","unstructured":"RangakaMX,WilkinsonKA,GlynnJRet al.Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis.Lancet Infect Dis2012; 12:45\u201355.","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","first-page":"S1120","DOI":"10.1093\/infdis\/jir410","article-title":"Interferon-\u03b3 release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis","volume":"204","author":"Metcalfe JZ","year":"2011","unstructured":"MetcalfeJZ,EverettCK,SteingartKRet al.Interferon-\u03b3 release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis.J Infect Dis2011; 204:S1120\u2013S1129.","journal-title":"J Infect Dis"},{"key":"e_1_3_2_13_1","first-page":"895","article-title":"Tuberculin reactivity and the risk of tuberculosis: a review","volume":"4","author":"Watkins RE","year":"2000","unstructured":"WatkinsRE,BrennanR,PlantAJ .Tuberculin reactivity and the risk of tuberculosis: a review.Int J Tuberc Lung Dis2000; 4:895\u2013903.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_14_1","author":"World Health Organization","year":"2010","unstructured":"World Health Organization.Global tuberculosis control: a short update to the 2009 Report.Geneva:WHO,2010.http:\/\/www.who.int\/tb\/features_archive\/globalreport09_update_8dec09\/en\/ (accessed 9 September 2015).","journal-title":"Global tuberculosis control: a short update to the 2009 Report"},{"key":"e_1_3_2_15_1","first-page":"1","article-title":"Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli","volume":"19","author":"Sutherland I","year":"1976","unstructured":"SutherlandI .Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli.Adv Tuberc Res1976; 19:1\u201363.","journal-title":"Adv Tuberc Res"},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/00007890-199705150-00015","article-title":"Clinical presentation and outcome of tuberculosis in kidney, liver and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA","volume":"63","author":"Aguado JM","year":"1997","unstructured":"AguadoJM,HerreroJA,GavaldaJet al.Clinical presentation and outcome of tuberculosis in kidney, liver and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.Transplantation1997; 63:1278\u20131286.","journal-title":"Transplantation"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00007890-199601270-00008","article-title":"The high incidence of tuberculosis among renal transplant recipients in India","volume":"61","author":"Sakhuja V","year":"1996","unstructured":"SakhujaV,JhaV,VarmaPPet al.The high incidence of tuberculosis among renal transplant recipients in India.Transplantation1996; 61:211\u2013215.","journal-title":"Transplantation"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(80)90166-7","article-title":"Tuberculosis in patients with end-stage renal disease","volume":"68","author":"Andrew OT","year":"1980","unstructured":"AndrewOT,SchoenfeldPY,HopewellPCet al.Tuberculosis in patients with end-stage renal disease.Am J Med1980; 68:59\u201365.","journal-title":"Am J Med"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(79)90240-7","article-title":"Tuberculosis in patients undergoing maintenance hemodialysis","volume":"67","author":"Lundin AP","year":"1979","unstructured":"LundinAP,AdlerAJ,BerlyneGMet al.Tuberculosis in patients undergoing maintenance hemodialysis.Am J Med1979; 67:597\u2013602.","journal-title":"Am J Med"},{"key":"e_1_3_2_20_1","first-page":"14","article-title":"Tuberculosis in dialysis patients","volume":"17","author":"Belcon MC","year":"1982","unstructured":"BelconMC,SmithEK,KahanaLMet al.Tuberculosis in dialysis patients.Clin Nephrol 1982; 17:14\u201318.","journal-title":"Clin Nephrol"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1525-139X.2003.03010.x","article-title":"Tuberculosis and chronic renal disease","volume":"16","author":"Hussein MM","year":"2003","unstructured":"HusseinMM,MooijJM,RoujoulehH .Tuberculosis and chronic renal disease.Semin Dial2003; 16:38\u201344.","journal-title":"Semin Dial"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET Consensus Statement","volume":"36","author":"Solovic I","year":"2010","unstructured":"SolovicI,SesterM,Gomez-ReinoJJet al.The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET Consensus Statement.Eur Respir J2010; 36:1185\u20131206.","journal-title":"Eur Respir J"},{"key":"e_1_3_2_23_1","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1164\/ajrccm.150.5.7952577","article-title":"The epidemiology of tuberculosis in gold miners with silicosis","volume":"150","author":"Cowie RL","year":"1994","unstructured":"CowieRL .The epidemiology of tuberculosis in gold miners with silicosis.Am J Respir Crit Care Med1994; 150:1460\u20131462.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_2_24_1","first-page":"605","article-title":"Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service","volume":"104","author":"Grzybowski S","year":"1971","unstructured":"GrzybowskiS,FishautH,RoweJet al.Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service.Am Rev Respir Dis1971; 104:605\u2013608.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_25_1","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3201\/eid1909.120200","article-title":"High rates of Mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991\u20132010, Italy","volume":"19","author":"Baussano I","year":"2013","unstructured":"BaussanoI,MercadanteS,PareekMet al.High rates of Mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991\u20132010, Italy.Emerg Infect Dis2013; 19:1437\u20131445.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jinf.2014.06.019","article-title":"Risk of tuberculosis among healthcare workers in an intermediate-burden country: a nationwide population study","volume":"69","author":"Chu H","year":"2014","unstructured":"ChuH,ShihCJ,LeeYJet al.Risk of tuberculosis among healthcare workers in an intermediate-burden country: a nationwide population study.J Infect2014; 69:525\u2013532.","journal-title":"J Infect"},{"key":"e_1_3_2_27_1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5588\/ijtld.11.0503","article-title":"The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis","volume":"15","author":"Harries AD","year":"2011","unstructured":"HarriesAD,LinY,SatyanarayanaSet al.The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis.Int J Tuberc Lung Dis2011; 15:1436\u20131444.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_28_1","doi-asserted-by":"crossref","first-page":"e000666","DOI":"10.1136\/bmjopen-2011-000666","article-title":"Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study","volume":"2","author":"Dobler CC","year":"2012","unstructured":"DoblerCC,FlackJR,MarksGB .Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study.BMJ Open2012; 2:e000666.","journal-title":"BMJ Open"},{"key":"e_1_3_2_29_1","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon CY","year":"2008","unstructured":"JeonCY,MurrayMB .Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.PLoS Med2008; 5:e152.","journal-title":"PLoS Med"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0021-9681(57)90007-3","article-title":"Diabetes mellitus and pulmonary tuberculosis","volume":"6","author":"Boucot KR","year":"1957","unstructured":"BoucotKR .Diabetes mellitus and pulmonary tuberculosis.J Chronic Dis1957; 6:256\u2013279.","journal-title":"J Chronic Dis"},{"key":"e_1_3_2_31_1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0962-8479(95)90529-4","article-title":"Incidence of pulmonary tuberculosis among diabetics","volume":"76","author":"Kim SJ","year":"1995","unstructured":"KimSJ,HongYP,LewWJet al.Incidence of pulmonary tuberculosis among diabetics.Tubercle Lung Dis1995; 76:529\u2013533.","journal-title":"Tubercle Lung Dis"},{"key":"e_1_3_2_32_1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/cid\/cir939","article-title":"The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study","volume":"54","author":"Baker MA","year":"2012","unstructured":"BakerMA,LinHH,ChangHYet al.The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study.Clin Infect Dis2012; 54:818\u2013825.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_33_1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0962-8479(96)90052-0","article-title":"Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case control study","volume":"77","author":"Altet MN","year":"1996","unstructured":"AltetMN,AlcaideJ,PlansPet al.Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case control study.Tubercle Lung Dis1996; 77:537\u2013544.","journal-title":"Tubercle Lung Dis"},{"key":"e_1_3_2_34_1","first-page":"1049","article-title":"Tobacco and tuberculosis: a qualitative systematic review and meta- analysis","volume":"11","author":"Slama K","year":"2007","unstructured":"SlamaK,ChiangCY,EnarsonDAet al.Tobacco and tuberculosis: a qualitative systematic review and meta- analysis.Int J Tuberc Lung Dis2007; 11:1049\u20131061.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_35_1","first-page":"942","article-title":"Smoking and tuberculosis: an association overlooked","volume":"6","author":"Maurya V","year":"2002","unstructured":"MauryaV,VijayanVK,ShahA .Smoking and tuberculosis: an association overlooked.Int J Tuberc Lung Dis2002; 6:942\u2013951.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_36_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick SS","year":"2006","unstructured":"JickSS,LiebermanES,RahmanMUet al.Glucocorticoid use, other associated factors, and the risk of tuberculosis.Arthritis Rheum2006; 55:19\u201326.","journal-title":"Arthritis Rheum"},{"key":"e_1_3_2_37_1","first-page":"517","article-title":"Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build","volume":"76","author":"Palmer CE","year":"1957","unstructured":"PalmerCE,JablonS,EdwardsPQ .Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build.Am Rev Tuberc1957; 76:517\u2013539.","journal-title":"Am Rev Tuberc"},{"key":"e_1_3_2_38_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.aje.a112105","article-title":"Frost revisited: the modern epidemiology of tuberculosis","volume":"101","author":"Comstock GW","year":"1975","unstructured":"ComstockGW .Frost revisited: the modern epidemiology of tuberculosis.Am J Epidemiol1975; 101:363\u2013382.","journal-title":"Am J Epidemiol"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858"},{"key":"e_1_3_2_40_1","doi-asserted-by":"crossref","unstructured":"World Health Organization.Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: WHO 2011.Available at http:\/\/www.who.int\/HIV\/pub\/tb\/9789241500708\/en\/ (accessed 17 October 2015).","DOI":"10.11604\/pamj.2014.17.26.2641"},{"key":"e_1_3_2_41_1","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis infection . Geneva: WHO 2015.Available at http:\/\/www.who.int\/tb\/publications\/ltbi_document_page\/en\/ (accessed 23 October 2015)."},{"key":"e_1_3_2_42_1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archinte.1982.00340180046010","article-title":"Mycobacterial infections in renal transplant patients","volume":"142","author":"Lloveras J","year":"1982","unstructured":"LloverasJ,PetersonPK,SimmonsRLet al.Mycobacterial infections in renal transplant patients.Arch Intern Med1982; 142:888\u2013892.","journal-title":"Arch Intern Med"},{"key":"e_1_3_2_43_1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/clinids\/5.2.216","article-title":"Mycobacterial infections in renal transplant patients: report of 5 cases and review of literature","volume":"5","author":"Lichtenstein IH","year":"1983","unstructured":"LichtensteinIH,MacGregorRR .Mycobacterial infections in renal transplant patients: report of 5 cases and review of literature.Rev Infect Dis1983; 5:216\u2013226.","journal-title":"Rev Infect Dis"},{"key":"e_1_3_2_44_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","article-title":"A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong","volume":"145","author":"Hong Kong Chest Service\/Tuberculosis Research Centre, Madras\/British Medical Research Council","year":"1992","unstructured":"Hong Kong Chest Service\/Tuberculosis Research Centre, Madras\/British Medical Research Council.A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong.Am Rev Respir Dis1992; 145:36\u201341.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_45_1","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group","volume":"354","author":"Maini R","year":"1999","unstructured":"MainiR,St ClairEW,BreedveldFet al.Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.Lancet1999; 354:1932\u20131939.","journal-title":"Lancet"},{"key":"e_1_3_2_46_1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane J","year":"2001","unstructured":"KeaneJ,GershonS,WiseRPet al.Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.N Engl J Med2001; 345:1098\u20131104.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_47_1","first-page":"247","article-title":"Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience","volume":"31","author":"Fonseca JE","year":"2006","unstructured":"FonsecaJE,CanhaoH,SilvaCet al.Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience.Acta Reumatol Port2006; 31:247\u2013253.","journal-title":"Acta Reumatol Port"},{"key":"e_1_3_2_48_1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/506935","article-title":"Antirheumatic drugs and the risk of tuberculosis","volume":"43","author":"Brassard P","year":"2006","unstructured":"BrassardP,KezouhA,SuissaS .Antirheumatic drugs and the risk of tuberculosis.Clin Infect Dis2006; 43:717\u2013722.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150057"},{"key":"e_1_3_2_50_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/thx.2010.144295","article-title":"Guidelines for prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease","volume":"65","author":"British Thoracic Society Standards of Care Committee, Joint Tuberculosis Committee, Milburn H, et al","year":"2010","unstructured":"British Thoracic Society Standards of Care Committee, Joint Tuberculosis Committee, Milburn H, et al.Guidelines for prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease.Thorax2010; 65:557\u2013570.","journal-title":"Thorax"},{"key":"e_1_3_2_51_1","first-page":"21","article-title":"Treatment Guidelines for Latent Tuberculosis Infection","volume":"89","author":"Prevention Committee of the Japanese Society for Tuberculosis, Treatment Committee of the Japanese Society for Tuberculosis","year":"2014","unstructured":"Prevention Committee of the Japanese Society for Tuberculosis, Treatment Committee of the Japanese Society for Tuberculosis.Treatment Guidelines for Latent Tuberculosis Infection.Kekkaku2014; 89:21\u201337.","journal-title":"Kekkaku"},{"key":"e_1_3_2_52_1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000045828","article-title":"Should tuberculosis prophylaxis be given to chronically dialyzed patients?","volume":"86","author":"Cengiz K","year":"2000","unstructured":"CengizK .Should tuberculosis prophylaxis be given to chronically dialyzed patients?Nephron2000; 86:411\u2013413.","journal-title":"Nephron"},{"key":"e_1_3_2_53_1","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","author":"International Union Against Tuberculosis Committee on prophylaxis","year":"1982","unstructured":"International Union Against Tuberculosis Committee on prophylaxis.Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial.Bull World Health Organ1982; 60:555\u2013564.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_2_54_1","first-page":"401","article-title":"Tuberculosis Epidemiologic Studies Consortium. Latent tuberculosis infection treatment acceptance and completion in 2002 in the United States and Canada","volume":"137","author":"Horsburgh CR","year":"2010","unstructured":"HorsburghCR,GoldbergS,BethelJet al.Tuberculosis Epidemiologic Studies Consortium. Latent tuberculosis infection treatment acceptance and completion in 2002 in the United States and Canada.Chest2010; 137:401\u2013409.","journal-title":"Chest"},{"key":"e_1_3_2_55_1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1378\/chest.103.6.1670","article-title":"Results of screening for tuberculosis in foreign-born persons applying for adjustment of immigration status","volume":"103","author":"Blum RN","year":"1993","unstructured":"BlumRN,PolishLB,TapyJMet al.Results of screening for tuberculosis in foreign-born persons applying for adjustment of immigration status.Chest1993; 103:1670\u20131674.","journal-title":"Chest"},{"key":"e_1_3_2_56_1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.300.4.405","article-title":"Tuberculosis among foreign-born persons in the United States","volume":"300","author":"Cain KP","year":"2008","unstructured":"CainKP,BenoitSR,WinstonCAet al.Tuberculosis among foreign-born persons in the United States.JAMA2008; 300:405\u2013412.","journal-title":"JAMA"},{"key":"e_1_3_2_57_1","first-page":"1422","article-title":"Evaluation of immigrant","volume":"18","author":"Pareek M","year":"2012","unstructured":"PareekM,BaussanoI,AbudakarIet al.Evaluation of immigrant.Emerg Infect Dis2012; 18:1422\u20131429.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_58_1","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.00098509","article-title":"Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts","volume":"35","author":"Kik SV","year":"2010","unstructured":"KikSV,FrankenWP,MensenMet al.Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts.Eur Respir J2010; 35:1346\u20131353.","journal-title":"Eur Respir J"},{"key":"e_1_3_2_59_1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/thoraxjnl-2011-201542","article-title":"Community-based evaluation of immigrant tuberculosis screening using interferon \u03b3 release assays and tuberculin skin testing: observational study and economic analysis","volume":"68","author":"Pareek M","year":"2013","unstructured":"PareekM,BondM,ShoreyJet al.Community-based evaluation of immigrant tuberculosis screening using interferon \u03b3 release assays and tuberculin skin testing: observational study and economic analysis.Thorax2013; 68:230\u2013239.","journal-title":"Thorax"},{"key":"e_1_3_2_60_1","unstructured":"National Institute for Health and Clinical Excellence: NICE clinical guideline 117. Tuberculosis: clinical diagnosis and management of tuberculosis and measures for its prevention and control. London 2011."},{"key":"e_1_3_2_61_1","first-page":"254","article-title":"Latent tuberculosis infection screening in healthcare workers in four large hospitals in Santiago, Chile","volume":"31","author":"Hern\u00e1ndez M","year":"2014","unstructured":"Hern\u00e1ndezM,CasarC,Garc\u00edaJet al.Latent tuberculosis infection screening in healthcare workers in four large hospitals in Santiago, Chile.Rev Chilena Infectol2014; 31:254\u2013260.","journal-title":"Rev Chilena Infectol"},{"key":"e_1_3_2_62_1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/arrd.1982.125.5.559","article-title":"Nosocomial tuberculosis","volume":"125","author":"Catanzaro A","year":"1982","unstructured":"CatanzaroA .Nosocomial tuberculosis.Am Rev Respir Dis1982; 125:559\u2013562.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_63_1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1164\/ajrccm\/142.3.505","article-title":"Occupational tuberculosis infections among pulmonary physicians in training","volume":"142","author":"Malasky C","year":"1990","unstructured":"MalaskyC,JordanT,PotulskiFet al.Occupational tuberculosis infections among pulmonary physicians in training.Am Rev Respir Dis1990; 142:505\u2013507.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_64_1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/ajrccm\/142.3.501","article-title":"Dodging droplet nuclei: reducing the probability of nosocomial tuberculosis transmission in the AIDS era","volume":"140","author":"Nardell EA","year":"1990","unstructured":"NardellEA .Dodging droplet nuclei: reducing the probability of nosocomial tuberculosis transmission in the AIDS era.Am Rev Respir Dis1990; 140:501\u2013503.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_65_1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/ajrccm\/136.4.803","article-title":"Annual tuberculosis screening of hospital employees-an idea whose time has not passed (Editorial)","volume":"136","author":"Stead WW","year":"1987","unstructured":"SteadWW .Annual tuberculosis screening of hospital employees-an idea whose time has not passed (Editorial).Am Rev Respir Dis1987; 136:803\u2013804.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_66_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.1992.03480030047035","article-title":"Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users","volume":"267","author":"Graham NM","year":"1992","unstructured":"GrahamNM,NelsonKE,SolomonLet al.Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.JAMA1992; 267:369\u2013372.","journal-title":"JAMA"},{"key":"e_1_3_2_67_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.1994.03520060055032","article-title":"HIV and tuberculosis infection in San Francisco\u2019s homeless adults","volume":"272","author":"Zolopa AR","year":"1994","unstructured":"ZolopaAR,HahnJA,GorterRet al.HIV and tuberculosis infection in San Francisco\u2019s homeless adults.JAMA1994; 272:455\u2013461.","journal-title":"JAMA"},{"key":"e_1_3_2_68_1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bmj.314.7090.1341","article-title":"Community marginalization and the diffusion of disease and disorder in the United States","volume":"314","author":"Wallace R","year":"1997","unstructured":"WallaceR,WallaceD .Community marginalization and the diffusion of disease and disorder in the United States.BMJ1997; 314:1341\u20131345.","journal-title":"BMJ"},{"key":"e_1_3_2_69_1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jech.2009.094375","article-title":"Tuberculosis in UK prisoners: a challenge for control","volume":"64","author":"Anderson C","year":"2010","unstructured":"AndersonC,StoryA,BrownTet al.Tuberculosis in UK prisoners: a challenge for control.J Epidemiol Community Health2010; 64:373\u2013376.","journal-title":"J Epidemiol Community Health"},{"key":"e_1_3_2_70_1","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/aje\/kwn075","article-title":"Diabetic control and risk of tuberculosis: a cohort study","volume":"167","author":"Leung CC","year":"2008","unstructured":"LeungCC,LamTH,ChanWMet al.Diabetic control and risk of tuberculosis: a cohort study.Am J Epidemiol2008; 167:1486\u20131494.","journal-title":"Am J Epidemiol"},{"key":"e_1_3_2_71_1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tube.2014.08.010","article-title":"Tobacco exposure and susceptibility to tuberculosis: is there a smoking gun?","volume":"94","author":"Chan ED","year":"2014","unstructured":"ChanED,KinneyWH,HondaJRet al.Tobacco exposure and susceptibility to tuberculosis: is there a smoking gun?Tuberculosis2014; 94:544\u2013550.","journal-title":"Tuberculosis"},{"key":"e_1_3_2_72_1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/rccm.201006-0861ED","article-title":"Should cigarette smoke exposure be a criterion to treat latent tuberculous infection?","volume":"182","author":"Chan ED","year":"2010","unstructured":"ChanED,KeaneJ,IsemanMD .Should cigarette smoke exposure be a criterion to treat latent tuberculous infection?Am J Respir Crit Care Med2010; 182:990\u2013992.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_2_73_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1183\/09031936.00072909","article-title":"Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD","volume":"35","author":"van Zyl Smit RN","year":"2010","unstructured":"van Zyl SmitRN,PaiM,YewWWet al.Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.Eur Respir J2010; 35:27\u201333.","journal-title":"Eur Respir J"},{"key":"e_1_3_2_74_1","first-page":"419","article-title":"The use of isoniazid among household contacts of open cases of pulmonary tuberculosis","volume":"33","author":"Egsmose T","year":"1965","unstructured":"EgsmoseT,Ang\u2019awaJO,PotiSJ .The use of isoniazid among household contacts of open cases of pulmonary tuberculosis.Bull World Health Organ1965; 33:419\u2013433.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_2_75_1","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"Comstock GW","year":"1999","unstructured":"ComstockGW .How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?Int J Tuberc Lung Dis1999; 3:847\u2013850.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_76_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMoa1214289","article-title":"A trial of mass isoniazid preventive therapy for tuberculosis control","volume":"370","author":"Churchyard GJ","year":"2014","unstructured":"ChurchyardGJ,FieldingKL,LewisJJet al.A trial of mass isoniazid preventive therapy for tuberculosis control.N Engl J Med2014; 370:301\u2013310.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_77_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/rccm.200404-478OC","article-title":"Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months","volume":"170","author":"Menzies D","year":"2004","unstructured":"MenziesD,DionMJ,RabinovitchBet al.Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months.Am J Respir Crit Care Med2004; 170:445\u2013449.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_2_78_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","article-title":"Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial","volume":"149","author":"Menzies D","year":"2008","unstructured":"MenziesD,LongR,TrajmanAet al.Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial.Ann Intern Med2008; 149:689\u2013697.","journal-title":"Ann Intern Med"},{"key":"e_1_3_2_79_1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.200901-0153OC","article-title":"Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection","volume":"179","author":"Holland DP","year":"2009","unstructured":"HollandDP,SandersGD,HamiltonCDet al.Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.Am J Respir Crit Care Med2009; 179:1055\u20131060.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_2_80_1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/thorax.55.11.887","article-title":"Control and prevention of tuberculosis in the United Kingdom: code of practice 2000","volume":"55","author":"Joint Tuberculosis Committee of the British Thoracic Society","year":"2000","unstructured":"Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000.Thorax2000; 55:887\u2013901.","journal-title":"Thorax"},{"key":"e_1_3_2_81_1","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling TR","year":"2011","unstructured":"SterlingTR,VillarinoME,BorisovASet al.Three months of rifapentine and isoniazid for latent tuberculosis infection.N Engl J Med2011; 365:2155\u20132166.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_82_1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/civ323","article-title":"Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study","volume":"61","author":"Sterling TR","year":"2015","unstructured":"SterlingTR,MoroRN,BorisovASet al.Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study.Clin Infect Dis2015; 61:527\u2013535.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_83_1","first-page":"1445","article-title":"Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on Aids, the Adult Aids Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group","volume":"283","author":"Gordin F","year":"2000","unstructured":"GordinF,ChaissonRE,MattsJPet al.Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on Aids, the Adult Aids Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.JAMA2000; 283:1445\u20131450.","journal-title":"JAMA"},{"key":"e_1_3_2_84_1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey NA","year":"1998","unstructured":"HalseyNA,CoberlyJS,DesormeauxJet al.Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.Lancet1998; 351:786\u2013792.","journal-title":"Lancet"},{"key":"e_1_3_2_85_1","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1001\/jama.285.20.2572","article-title":"Fatal and Severe Hepatitis Associated with Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection\u2013New York and Georgia, 2000","volume":"285","author":"From the Centers for Disease Control and Prevention","year":"2001","unstructured":"From the Centers for Disease Control and Prevention. Fatal and Severe Hepatitis Associated with Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection\u2013New York and Georgia, 2000.JAMA2001; 285:2572\u20132573.","journal-title":"JAMA"},{"key":"e_1_3_2_86_1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.286.12.1445","article-title":"Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society\/CDC Recommendations\u2013United States, 2001","volume":"286","author":"From the Centers for Disease Control and Prevention","year":"2001","unstructured":"From the Centers for Disease Control and Prevention .Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society\/CDC Recommendations\u2013United States, 2001.JAMA2001; 286:1445\u20131446.","journal-title":"JAMA"},{"key":"e_1_3_2_87_1","first-page":"735","article-title":"Update: adverse event data and revised. American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection\u2013United States, 2003","volume":"52","author":"Centers for Disease Control and Prevention, American Thoracic Society","year":"2003","unstructured":"Centers for Disease Control and Prevention, American Thoracic Society.Update: adverse event data and revised. American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection\u2013United States, 2003.MMWR Morb Mortal Wkly Rep2003; 52:735\u2013739.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_88_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","article-title":"Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection","volume":"342","author":"Pape JW","year":"1993","unstructured":"PapeJW,JeanSS,HoJLet al.Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.Lancet1993; 342:268\u2013272.","journal-title":"Lancet"},{"key":"e_1_3_2_89_1","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.293.22.2719","article-title":"Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study","volume":"293","author":"Grant AD","year":"2005","unstructured":"GrantAD,CharalambousS,FieldingKLet al.Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.JAMA2005; 293:2719\u20132725.","journal-title":"JAMA"},{"key":"e_1_3_2_90_1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration","volume":"337","author":"Whalen CC","year":"1997","unstructured":"WhalenCC,JohnsonJL,OkweraAet al.A trial of three regimens to prevent tuberculosis in ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.N Engl J Med1997; 337:801\u2013808.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_91_1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(14)60162-8","article-title":"Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial","volume":"384","author":"Rangaka MX","year":"2014","unstructured":"RangakaMX,WilkinsonRJ,BoulleAet al.Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.Lancet2014; 384:682\u2013690.","journal-title":"Lancet"},{"key":"e_1_3_2_92_1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199903110-00009","article-title":"Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials","volume":"13","author":"Bucher HC","year":"1999","unstructured":"BucherHC,GriffithLE,GuyattGHet al.Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.AIDS1999; 13:501\u2013507.","journal-title":"AIDS"},{"key":"e_1_3_2_93_1","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Samandari T","year":"2011","unstructured":"SamandariT,AgizewTB,NyirendaSet al.6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.Lancet2011; 377:1588\u20131598.","journal-title":"Lancet"},{"key":"e_1_3_2_94_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson NA","year":"2011","unstructured":"MartinsonNA,BarnesGL,MoultonLHet al.New regimens to prevent tuberculosis in adults with HIV infection.N Engl J Med2011; 365:11\u201320.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_95_1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199457110-00029","article-title":"A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients","volume":"57","author":"John GT","year":"1994","unstructured":"JohnGT,ThomasPP,ThomasMet al.A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients.Transplantation1994; 57:1683\u20131684.","journal-title":"Transplantation"},{"key":"e_1_3_2_96_1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/ndt\/gfp489","article-title":"Use of isoniazid chemoprophylaxis in renal transplant recipients","volume":"25","author":"Naqvi R","year":"2010","unstructured":"NaqviR,NaqviA,AkhtarSet al.Use of isoniazid chemoprophylaxis in renal transplant recipients.Nephrol Dial Transplant2010; 25:634\u2013637.","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_3_2_97_1","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1111\/ajt.12470","article-title":"Results of implementation of preventive recommendations for tuberculosis after renal transplantation in an endemic area","volume":"13","author":"de Lemos AS","year":"2013","unstructured":"de LemosAS,VieiraMA,HalpernMet al.Results of implementation of preventive recommendations for tuberculosis after renal transplantation in an endemic area.Am J Transplant2013; 13:3230\u20133235.","journal-title":"Am J Transplant"},{"key":"e_1_3_2_98_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/TP.0b013e3181ecea8d","article-title":"Tuberculosis in renal transplant recipients: the evidence for prophylaxis","volume":"90","author":"Currie AC","year":"2010","unstructured":"CurrieAC,KnightSR,MorrisPJ .Tuberculosis in renal transplant recipients: the evidence for prophylaxis.Transplantation2010; 90:695\u2013704.","journal-title":"Transplantation"},{"key":"e_1_3_2_99_1","first-page":"1127","article-title":"Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis","volume":"10","author":"Sichletidis L","year":"2006","unstructured":"SichletidisL,SettasL,SpyratosDet al.Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.Int J Tuberc Lung Dis2006; 10:1127\u20131132.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_100_1","first-page":"706","article-title":"Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers","volume":"34","author":"Seong SS","year":"2007","unstructured":"SeongSS,ChoiCB,WooJHet al.Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.J Rheumatol2007; 34:706\u2013711.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_101_1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"Gomez-Reino JJ","year":"2007","unstructured":"Gomez-ReinoJJ,CarmonaL,Angel DescalzoMet al.Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.Arthritis Rheum2007; 57:756\u2013761.","journal-title":"Arthritis Rheum"},{"key":"e_1_3_2_102_1","first-page":"679","article-title":"Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong\u2013the role of TNF blockers in an area of high tuberculosis burden","volume":"28","author":"Tam LS","year":"2010","unstructured":"TamLS,LeungCC,YingSKet al.Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong\u2013the role of TNF blockers in an area of high tuberculosis burden.Clin Exp Rheumatol2010; 28:679\u2013685.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_103_1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5588\/ijtld.11.0437","article-title":"Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews","volume":"16","author":"van der Werf MJ","year":"2012","unstructured":"van der WerfMJ,LangendamMW,SandgrenAet al.Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews.Int J Tuberc Lung Dis2012; 16:288\u2013296.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_104_1","first-page":"CD005435","article-title":"Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis","volume":"2","author":"Fraser A","year":"2006","unstructured":"FraserA,PaulM,AttamnaAet al.Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis.Cochrane Database Syst Rev2006; 2:CD005435.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_105_1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009\u20132012","volume":"18","author":"Bamrah S","year":"2014","unstructured":"BamrahS,BrostromR,DorinaFet al.Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009\u20132012.Int J Tuberc Lung Dis2014; 18:912\u2013918.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_106_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-3062.2005.00103.x","article-title":"Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy","volume":"7","author":"Vikrant S","year":"2005","unstructured":"VikrantS,AgarwalSK,GuptaSet al.Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.Transpl Infect Dis2005; 7:99\u2013108.","journal-title":"Transpl Infect Dis"}],"container-title":["Emerging Microbes & Infections"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/emi201610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/emi201610","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1038\/emi.2016.10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/emi201610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T08:40:10Z","timestamp":1695285610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1038\/emi.2016.10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1038\/emi.2016.10"],"URL":"https:\/\/doi.org\/10.1038\/emi.2016.10","relation":{},"ISSN":["2222-1751"],"issn-type":[{"value":"2222-1751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}